What Are the Long-Term Safety Profiles of PT-141 versus PDE5 Inhibitors?
PT-141 influences desire centrally with transient blood pressure effects, while PDE5 inhibitors enhance local blood flow with established cardiovascular safety.
HRTioJuly 19, 2025